Hesingue, France

Frédéric Stauffer

USPTO Granted Patents = 8 


Average Co-Inventor Count = 4.7

ph-index = 5

Forward Citations = 106(Granted Patents)


Location History:

  • Reinach, CH (2010 - 2013)
  • Basel, CH (2013 - 2014)
  • Hesingue, FR (2014 - 2018)

Company Filing History:


Years Active: 2010-2018

Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: Frédéric Stauffer: Innovator in Pharmaceutical Chemistry

Introduction

Frédéric Stauffer is a notable inventor based in Hesingue, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target critical biological pathways.

Latest Patents

Stauffer holds five patents, with his latest inventions focusing on oxazolidin-2-one compounds. These compounds are substituted pyrimidine derivatives that act as inhibitors of phosphatidylinositol-3-kinase (PI3K). The inventions include pharmaceutical compositions and methods for their manufacture, aimed at treating various conditions, diseases, and disorders that depend on PI3K.

Career Highlights

Frédéric Stauffer has established a successful career at Novartis AG, a leading global healthcare company. His work has been instrumental in advancing therapeutic options in the pharmaceutical industry.

Collaborations

Throughout his career, Stauffer has collaborated with esteemed colleagues such as Pascal Furet and Carlos Garcia-Echeverria. These partnerships have enhanced the innovation and development of his research projects.

Conclusion

Frédéric Stauffer's contributions to pharmaceutical chemistry and his innovative patents underscore his role as a key figure in the industry. His work continues to impact the development of new treatments for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…